Insider filing · MLTX
Simon Sturge
Director
profile →
MoonLake Immunotherapeutics
MLTX · Healthcare · 18 filings in 24 months
ticker →
Simon Sturge sold $9.2M of MoonLake Immunotherapeutics (MLTX)
Executed Oct 4 2024, disclosed Oct 8 2024, 4 days later.
Value, as filed
$9.2M
171,000 sh × $53.72
Executed
Oct 4 2024
the trade date, as filed
Disclosed
Oct 8 2024
4 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
SSSimon Sturge (Director) filed 1 Form 4 report in the past 24 months (0 purchases, 1 sale), most often in MoonLake Immunotherapeutics (MLTX). The largest single filing was $9.2M of MLTX (171,000 sh × $53.72, as filed), executed Oct 4 2024.
The name
MLTXHealthcare · MoonLake Immunotherapeutics, a clinical-stage biotechnology company, focuses on developing therapies for inflammatory skin and joint diseas…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→